The study to develop novel treatment for antibody-mediated rejection after organ transplantation.
Not Applicable
- Conditions
- post-transplant antibody-mediated rejection
- Registration Number
- JPRN-UMIN000031863
- Lead Sponsor
- Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
The cases with active infection. The cases with viable malignancy, excluding hepatocellular carcinoma which is rescued by liver transplantation. Any cases which are considered as inadequate to entry the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitized cases: the incidence of negativity of antibody, or the change of antibody titer The cases with antibody-mediated rejection: organ function or pathological finding
- Secondary Outcome Measures
Name Time Method